Cargando…

Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers

BACKGROUNDS: Salivary biomarkers hold huge potential for the non-invasive diagnosis of oral squamous cell carcinoma. Angiogenic factors and matrix-metalloproteinases (MMPs) are highly expressed in OSCC tissue, but their expression patterns in the saliva are unknown. This study aimed to analyze the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Meijuan, Zheng, Zhichao, Bai, Zhibao, Ouyang, Kexiong, Wu, Qiuyu, Xu, Shaofen, Huang, Lihuan, Jiang, Yingtong, Wang, Lijing, Gao, Jie, Pathak, Janak L., Wu, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092712/
https://www.ncbi.nlm.nih.gov/pubmed/35545767
http://dx.doi.org/10.1186/s12885-022-09630-0
_version_ 1784705190002163712
author Cai, Meijuan
Zheng, Zhichao
Bai, Zhibao
Ouyang, Kexiong
Wu, Qiuyu
Xu, Shaofen
Huang, Lihuan
Jiang, Yingtong
Wang, Lijing
Gao, Jie
Pathak, Janak L.
Wu, Lihong
author_facet Cai, Meijuan
Zheng, Zhichao
Bai, Zhibao
Ouyang, Kexiong
Wu, Qiuyu
Xu, Shaofen
Huang, Lihuan
Jiang, Yingtong
Wang, Lijing
Gao, Jie
Pathak, Janak L.
Wu, Lihong
author_sort Cai, Meijuan
collection PubMed
description BACKGROUNDS: Salivary biomarkers hold huge potential for the non-invasive diagnosis of oral squamous cell carcinoma. Angiogenic factors and matrix-metalloproteinases (MMPs) are highly expressed in OSCC tissue, but their expression patterns in the saliva are unknown. This study aimed to analyze the levels of angiogenic factors and MMPs in tumor tissue and saliva of OSCC patients. METHODS: OSCC-tissue, adjacent normal tissue (ANT), saliva from OSCC patients, and healthy controls were obtained. The expression patterns of angiogenic factors and MMPs were analyzed by immunohistochemistry, protein chip array, and RT-qPCR. RESULTS: Results showed higher expression of ANG, ANG-2, HGF, PIGF, VEGF, MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13, TIMP-1, and TIMP-2 in OSCC-tissues compared to the ANT. Among the overexpressed markers in OSCC-tissues, HGF, VEGF, PIGF, PDGF-BB, MMP-1, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13, and TIMP-2 were significantly upregulated in the saliva of OSCC patients compared to healthy controls. CONCLUSIONS: The levels of HGF, VEGF, PIGF, MMP-1, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13, and TIMP-2 were upregulated both in OSCC tissue and saliva of OSCC patients. Bioinformatic analysis revealed the correlation of these factors with patient survival and cancer functional states in head and neck cancer, indicating these factors as possible saliva-based non-invasive diagnostic/prognostic markers and therapeutic targets of OSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09630-0.
format Online
Article
Text
id pubmed-9092712
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90927122022-05-12 Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers Cai, Meijuan Zheng, Zhichao Bai, Zhibao Ouyang, Kexiong Wu, Qiuyu Xu, Shaofen Huang, Lihuan Jiang, Yingtong Wang, Lijing Gao, Jie Pathak, Janak L. Wu, Lihong BMC Cancer Research BACKGROUNDS: Salivary biomarkers hold huge potential for the non-invasive diagnosis of oral squamous cell carcinoma. Angiogenic factors and matrix-metalloproteinases (MMPs) are highly expressed in OSCC tissue, but their expression patterns in the saliva are unknown. This study aimed to analyze the levels of angiogenic factors and MMPs in tumor tissue and saliva of OSCC patients. METHODS: OSCC-tissue, adjacent normal tissue (ANT), saliva from OSCC patients, and healthy controls were obtained. The expression patterns of angiogenic factors and MMPs were analyzed by immunohistochemistry, protein chip array, and RT-qPCR. RESULTS: Results showed higher expression of ANG, ANG-2, HGF, PIGF, VEGF, MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13, TIMP-1, and TIMP-2 in OSCC-tissues compared to the ANT. Among the overexpressed markers in OSCC-tissues, HGF, VEGF, PIGF, PDGF-BB, MMP-1, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13, and TIMP-2 were significantly upregulated in the saliva of OSCC patients compared to healthy controls. CONCLUSIONS: The levels of HGF, VEGF, PIGF, MMP-1, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13, and TIMP-2 were upregulated both in OSCC tissue and saliva of OSCC patients. Bioinformatic analysis revealed the correlation of these factors with patient survival and cancer functional states in head and neck cancer, indicating these factors as possible saliva-based non-invasive diagnostic/prognostic markers and therapeutic targets of OSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09630-0. BioMed Central 2022-05-11 /pmc/articles/PMC9092712/ /pubmed/35545767 http://dx.doi.org/10.1186/s12885-022-09630-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cai, Meijuan
Zheng, Zhichao
Bai, Zhibao
Ouyang, Kexiong
Wu, Qiuyu
Xu, Shaofen
Huang, Lihuan
Jiang, Yingtong
Wang, Lijing
Gao, Jie
Pathak, Janak L.
Wu, Lihong
Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers
title Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers
title_full Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers
title_fullStr Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers
title_full_unstemmed Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers
title_short Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers
title_sort overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092712/
https://www.ncbi.nlm.nih.gov/pubmed/35545767
http://dx.doi.org/10.1186/s12885-022-09630-0
work_keys_str_mv AT caimeijuan overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT zhengzhichao overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT baizhibao overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT ouyangkexiong overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT wuqiuyu overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT xushaofen overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT huanglihuan overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT jiangyingtong overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT wanglijing overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT gaojie overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT pathakjanakl overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers
AT wulihong overexpressionofangiogenicfactorsandmatrixmetalloproteinasesinthesalivaoforalsquamouscellcarcinomapatientspotentialnoninvasivediagnosticandtherapeuticbiomarkers